One pharmacist drew attention to a massive pricing disparity on a key cancer drug, and that disparity may help to explain why our healthcare system here in America is known to be so expensive.
Brad Hart of Forest Park Pharmacy said in a viral social media post shared last week that the drug imatinib, also known as Gleevec, which is used to treat chronic myelogenous leukemia, costs a mere $7 for his business to purchase.
His pharmacy then adds $10, meaning customers can get the drug for only $17.
But Medicare pays a shocking $2,400 for the same drug, which is 34,000 percent more than what Forest Park Pharmacy is paying.
According to a report from the National Cancer Institute, Gleevec is nothing short of a “landmark drug that has vastly improved the outcomes of patients” with chronic myelogenous leukemia.
The drug was therefore filled 250,000 times in a single year, costing Medicare a massive $600 million, according to Hart.
“If every one of those scripts was filled at our pharmacy, instead of through Medicare, it would’ve cost $4 million,” Hart described in the video.
...
Applies to everyone with prescription insurance. Read up on pharmacy benefit managers PBM.
Then go to mail order pharmacy and pay cash for less than your (((insurance))) co-pay at the chain pharmacy
